ARCHIVES

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

WHO Names Brinker As Goodwill Ambassador

May 29, 2009